nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefalotin—SLC22A7—Fluorouracil—urinary bladder cancer	0.267	0.306	CbGbCtD
Cefalotin—SLC22A11—Methotrexate—urinary bladder cancer	0.154	0.177	CbGbCtD
Cefalotin—SLC22A7—Methotrexate—urinary bladder cancer	0.147	0.169	CbGbCtD
Cefalotin—ALB—Fluorouracil—urinary bladder cancer	0.0966	0.111	CbGbCtD
Cefalotin—SLC22A8—Methotrexate—urinary bladder cancer	0.0898	0.103	CbGbCtD
Cefalotin—SLC22A6—Methotrexate—urinary bladder cancer	0.0626	0.0719	CbGbCtD
Cefalotin—ALB—Methotrexate—urinary bladder cancer	0.0533	0.0612	CbGbCtD
Cefalotin—PTPN7—prostate gland—urinary bladder cancer	0.0165	0.145	CbGeAlD
Cefalotin—SLC22A8—urine—urinary bladder cancer	0.0128	0.113	CbGeAlD
Cefalotin—PTPN7—vagina—urinary bladder cancer	0.00812	0.0716	CbGeAlD
Cefalotin—SLC22A11—renal system—urinary bladder cancer	0.00555	0.0489	CbGeAlD
Cefalotin—SLC22A7—renal system—urinary bladder cancer	0.00541	0.0477	CbGeAlD
Cefalotin—PTPN7—lymph node—urinary bladder cancer	0.00526	0.0463	CbGeAlD
Cefalotin—SLC15A1—epithelium—urinary bladder cancer	0.00469	0.0413	CbGeAlD
Cefalotin—SLC22A8—prostate gland—urinary bladder cancer	0.00459	0.0405	CbGeAlD
Cefalotin—SLC22A11—female reproductive system—urinary bladder cancer	0.00444	0.0392	CbGeAlD
Cefalotin—SLC15A1—renal system—urinary bladder cancer	0.00435	0.0383	CbGeAlD
Cefalotin—SLC15A2—prostate gland—urinary bladder cancer	0.00399	0.0352	CbGeAlD
Cefalotin—SLC22A5—prostate gland—urinary bladder cancer	0.00347	0.0306	CbGeAlD
Cefalotin—SLC15A2—seminal vesicle—urinary bladder cancer	0.00337	0.0297	CbGeAlD
Cefalotin—SLC15A1—vagina—urinary bladder cancer	0.00315	0.0278	CbGeAlD
Cefalotin—SLC22A8—renal system—urinary bladder cancer	0.00313	0.0276	CbGeAlD
Cefalotin—SLC22A5—seminal vesicle—urinary bladder cancer	0.00293	0.0259	CbGeAlD
Cefalotin—SLC15A2—renal system—urinary bladder cancer	0.00272	0.024	CbGeAlD
Cefalotin—SLC15A2—urethra—urinary bladder cancer	0.00267	0.0235	CbGeAlD
Cefalotin—SLC22A5—renal system—urinary bladder cancer	0.00236	0.0208	CbGeAlD
Cefalotin—SLC22A5—urethra—urinary bladder cancer	0.00232	0.0205	CbGeAlD
Cefalotin—SLC15A2—female reproductive system—urinary bladder cancer	0.00218	0.0192	CbGeAlD
Cefalotin—SLC15A2—vagina—urinary bladder cancer	0.00197	0.0174	CbGeAlD
Cefalotin—SLC22A5—female reproductive system—urinary bladder cancer	0.00189	0.0167	CbGeAlD
Cefalotin—SLC22A5—vagina—urinary bladder cancer	0.00171	0.0151	CbGeAlD
Cefalotin—Cefdinir—MPO—urinary bladder cancer	0.00154	0.502	CrCbGaD
Cefalotin—Cefaclor—MPO—urinary bladder cancer	0.00153	0.498	CrCbGaD
Cefalotin—ALB—lymph node—urinary bladder cancer	0.00153	0.0135	CbGeAlD
Cefalotin—SLC15A2—lymph node—urinary bladder cancer	0.00127	0.0112	CbGeAlD
Cefalotin—SLC22A5—lymph node—urinary bladder cancer	0.00111	0.00977	CbGeAlD
Cefalotin—PTPN7—Ras signaling in the CD4+ TCR pathway—KRAS—urinary bladder cancer	0.000823	0.0645	CbGpPWpGaD
Cefalotin—PTPN7—Downstream signaling in naïve CD8+ T cells—IFNA2—urinary bladder cancer	0.000742	0.0581	CbGpPWpGaD
Cefalotin—PTPN7—Ras signaling in the CD4+ TCR pathway—HRAS—urinary bladder cancer	0.0007	0.0548	CbGpPWpGaD
Cefalotin—SLC22A7—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.0006	0.047	CbGpPWpGaD
Cefalotin—SLC22A7—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.000468	0.0367	CbGpPWpGaD
Cefalotin—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000461	0.0361	CbGpPWpGaD
Cefalotin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000418	0.0327	CbGpPWpGaD
Cefalotin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000389	0.0304	CbGpPWpGaD
Cefalotin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000351	0.0275	CbGpPWpGaD
Cefalotin—PTPN7—Downstream signaling in naïve CD8+ T cells—IL2—urinary bladder cancer	0.00033	0.0258	CbGpPWpGaD
Cefalotin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000293	0.023	CbGpPWpGaD
Cefalotin—SLC22A7—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.000271	0.0212	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—FAS—urinary bladder cancer	0.000268	0.021	CbGpPWpGaD
Cefalotin—SLC22A7—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000252	0.0197	CbGpPWpGaD
Cefalotin—PTPN7—Downstream signaling in naïve CD8+ T cells—TNF—urinary bladder cancer	0.00024	0.0188	CbGpPWpGaD
Cefalotin—PTPN7—Downstream signaling in naïve CD8+ T cells—KRAS—urinary bladder cancer	0.000238	0.0187	CbGpPWpGaD
Cefalotin—SLC22A7—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000237	0.0186	CbGpPWpGaD
Cefalotin—SLC22A11—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000209	0.0164	CbGpPWpGaD
Cefalotin—PTPN7—Downstream signaling in naïve CD8+ T cells—HRAS—urinary bladder cancer	0.000202	0.0159	CbGpPWpGaD
Cefalotin—SLC15A2—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000193	0.0152	CbGpPWpGaD
Cefalotin—SLC22A7—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00019	0.0149	CbGpPWpGaD
Cefalotin—SLC15A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00018	0.0141	CbGpPWpGaD
Cefalotin—SLC22A5—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000177	0.0138	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—SLC19A1—urinary bladder cancer	0.000161	0.0126	CbGpPWpGaD
Cefalotin—SLC22A8—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00016	0.0125	CbGpPWpGaD
Cefalotin—SLC22A6—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000133	0.0104	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—MYC—urinary bladder cancer	0.000122	0.00956	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—EGFR—urinary bladder cancer	0.000119	0.00935	CbGpPWpGaD
Cefalotin—ALB—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.000114	0.00895	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—TNF—urinary bladder cancer	0.000114	0.00891	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—KRAS—urinary bladder cancer	0.000113	0.00884	CbGpPWpGaD
Cefalotin—ALB—Vitamin B12 Metabolism—MPO—urinary bladder cancer	0.00011	0.00864	CbGpPWpGaD
Cefalotin—SLC22A11—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000106	0.00833	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—TP53—urinary bladder cancer	0.0001	0.00785	CbGpPWpGaD
Cefalotin—SLC15A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	9.83e-05	0.0077	CbGpPWpGaD
Cefalotin—SLC22A7—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	9.65e-05	0.00756	CbGpPWpGaD
Cefalotin—SLC15A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	9.12e-05	0.00715	CbGpPWpGaD
Cefalotin—SLC22A7—Fluoropyrimidine Activity—TP53—urinary bladder cancer	8.99e-05	0.00705	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—MPO—urinary bladder cancer	8.97e-05	0.00703	CbGpPWpGaD
Cefalotin—SLC22A5—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	8.97e-05	0.00703	CbGpPWpGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	8.11e-05	0.00636	CbGpPWpGaD
Cefalotin—SLC22A11—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	7.69e-05	0.00602	CbGpPWpGaD
Cefalotin—ALB—Selenium Micronutrient Network—MPO—urinary bladder cancer	7.13e-05	0.00558	CbGpPWpGaD
Cefalotin—SLC15A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	7.11e-05	0.00557	CbGpPWpGaD
Cefalotin—SLC22A7—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	6.98e-05	0.00547	CbGpPWpGaD
Cefalotin—ALB—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	6.93e-05	0.00543	CbGpPWpGaD
Cefalotin—ALB—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	6.93e-05	0.00543	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	6.77e-05	0.0053	CbGpPWpGaD
Cefalotin—SLC15A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	6.59e-05	0.00517	CbGpPWpGaD
Cefalotin—SLC22A5—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	6.49e-05	0.00508	CbGpPWpGaD
Cefalotin—SLC22A11—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	6.27e-05	0.00491	CbGpPWpGaD
Cefalotin—ALB—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	6.1e-05	0.00478	CbGpPWpGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	5.87e-05	0.00459	CbGpPWpGaD
Cefalotin—SLC15A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	5.79e-05	0.00454	CbGpPWpGaD
Cefalotin—SLC22A7—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	5.69e-05	0.00446	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—SOD2—urinary bladder cancer	5.63e-05	0.00441	CbGpPWpGaD
Cefalotin—SLC15A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	5.38e-05	0.00421	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—GPX1—urinary bladder cancer	5.38e-05	0.00421	CbGpPWpGaD
Cefalotin—SLC22A5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	5.29e-05	0.00414	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—MTHFR—urinary bladder cancer	4.96e-05	0.00389	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	4.9e-05	0.00383	CbGpPWpGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	4.78e-05	0.00375	CbGpPWpGaD
Cefalotin—ALB—Selenium Micronutrient Network—SOD2—urinary bladder cancer	4.48e-05	0.00351	CbGpPWpGaD
Cefalotin—ALB—Selenium Micronutrient Network—GPX1—urinary bladder cancer	4.27e-05	0.00335	CbGpPWpGaD
Cefalotin—SLC22A11—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.23e-05	0.00332	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.99e-05	0.00313	CbGpPWpGaD
Cefalotin—ALB—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	3.94e-05	0.00309	CbGpPWpGaD
Cefalotin—SLC15A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.91e-05	0.00307	CbGpPWpGaD
Cefalotin—SLC22A7—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.84e-05	0.00301	CbGpPWpGaD
Cefalotin—SLC15A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.63e-05	0.00284	CbGpPWpGaD
Cefalotin—SLC22A5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.57e-05	0.0028	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	3.52e-05	0.00276	CbGpPWpGaD
Cefalotin—ALB—Platelet degranulation—IGF1—urinary bladder cancer	3.27e-05	0.00256	CbGpPWpGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.23e-05	0.00253	CbGpPWpGaD
Cefalotin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	3.12e-05	0.00244	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	3.05e-05	0.00239	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—IL2—urinary bladder cancer	2.93e-05	0.0023	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.7e-05	0.00211	CbGpPWpGaD
Cefalotin—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	2.63e-05	0.00206	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	2.54e-05	0.00199	CbGpPWpGaD
Cefalotin—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	2.51e-05	0.00197	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—TNF—urinary bladder cancer	2.14e-05	0.00167	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	2.07e-05	0.00163	CbGpPWpGaD
Cefalotin—SLC22A11—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.98e-05	0.00155	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—TP53—urinary bladder cancer	1.88e-05	0.00148	CbGpPWpGaD
Cefalotin—SLC15A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.83e-05	0.00143	CbGpPWpGaD
Cefalotin—SLC22A7—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.8e-05	0.00141	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTZ1—urinary bladder cancer	1.74e-05	0.00136	CbGpPWpGaD
Cefalotin—SLC15A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.7e-05	0.00133	CbGpPWpGaD
Cefalotin—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	1.7e-05	0.00133	CbGpPWpGaD
Cefalotin—SLC22A5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.67e-05	0.00131	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTO2—urinary bladder cancer	1.65e-05	0.00129	CbGpPWpGaD
Cefalotin—ALB—Metabolism—NAT1—urinary bladder cancer	1.65e-05	0.00129	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.62e-05	0.00127	CbGpPWpGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.51e-05	0.00118	CbGpPWpGaD
Cefalotin—ALB—Metabolism—UGT2B7—urinary bladder cancer	1.51e-05	0.00118	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	1.45e-05	0.00114	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.4e-05	0.0011	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CYP4B1—urinary bladder cancer	1.36e-05	0.00106	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	1.33e-05	0.00104	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—IFNA2—urinary bladder cancer	1.29e-05	0.00101	CbGpPWpGaD
Cefalotin—ALB—Metabolism—SLC19A1—urinary bladder cancer	1.28e-05	0.001	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.26e-05	0.000988	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PRSS3—urinary bladder cancer	1.25e-05	0.000979	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	1.12e-05	0.000874	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1e-05	0.000785	CbGpPWpGaD
Cefalotin—ALB—Metabolism—TYMP—urinary bladder cancer	9.99e-06	0.000782	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	9.73e-06	0.000762	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	9.59e-06	0.000751	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PLAU—urinary bladder cancer	9.18e-06	0.000719	CbGpPWpGaD
Cefalotin—ALB—Metabolism—NAT2—urinary bladder cancer	9.03e-06	0.000708	CbGpPWpGaD
Cefalotin—ALB—Metabolism—RRM2—urinary bladder cancer	7.8e-06	0.000611	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—CREBBP—urinary bladder cancer	7.57e-06	0.000593	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—IGF1—urinary bladder cancer	7.48e-06	0.000586	CbGpPWpGaD
Cefalotin—ALB—Metabolism—HPGDS—urinary bladder cancer	7.22e-06	0.000566	CbGpPWpGaD
Cefalotin—ALB—Metabolism—ENO2—urinary bladder cancer	7.22e-06	0.000566	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.18e-06	0.000562	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTT1—urinary bladder cancer	7e-06	0.000549	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.9e-06	0.00054	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—RHOA—urinary bladder cancer	6.85e-06	0.000537	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.56e-06	0.000514	CbGpPWpGaD
Cefalotin—ALB—Metabolism—NQO1—urinary bladder cancer	5.82e-06	0.000456	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—IL2—urinary bladder cancer	5.75e-06	0.00045	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.65e-06	0.000442	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—EP300—urinary bladder cancer	5.16e-06	0.000404	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—SRC—urinary bladder cancer	5.02e-06	0.000393	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.92e-06	0.000386	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTP1—urinary bladder cancer	4.85e-06	0.00038	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.7e-06	0.000368	CbGpPWpGaD
Cefalotin—ALB—Metabolism—TYMS—urinary bladder cancer	4.51e-06	0.000354	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTM1—urinary bladder cancer	4.46e-06	0.000349	CbGpPWpGaD
Cefalotin—ALB—Metabolism—NCOR1—urinary bladder cancer	4.46e-06	0.000349	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GPX1—urinary bladder cancer	4.27e-06	0.000335	CbGpPWpGaD
Cefalotin—ALB—Metabolism—ERCC2—urinary bladder cancer	4.19e-06	0.000329	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—KRAS—urinary bladder cancer	4.15e-06	0.000325	CbGpPWpGaD
Cefalotin—ALB—Metabolism—MTHFR—urinary bladder cancer	3.94e-06	0.000309	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—TP53—urinary bladder cancer	3.69e-06	0.000289	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—HRAS—urinary bladder cancer	3.53e-06	0.000277	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PPARG—urinary bladder cancer	3.2e-06	0.00025	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CREBBP—urinary bladder cancer	3.07e-06	0.000241	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PTGS2—urinary bladder cancer	2.51e-06	0.000197	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PTEN—urinary bladder cancer	2.19e-06	0.000172	CbGpPWpGaD
Cefalotin—ALB—Metabolism—EP300—urinary bladder cancer	2.09e-06	0.000164	CbGpPWpGaD
